Bladder Cancer | Proceedings From a Live Event Held in Conjunction with the 2022 Genitourinary Cancers Symposium

Featuring perspectives from Drs Shilpa Gupta, Daniel Petrylak and Guru Sonpavde, moderated by Dr Sumanta Pal, including the following topics: Introduction (0:00) Integrating Novel Agents into the Treatment Paradigm for Nonmetastatic Urothelial Bladder Cancer (UBC) — Sumanta Kumar Pal, MD (1:46) Current and Future Front-Line Management of Metastatic UBC (mUBC) — Shilpa Gupta, MD (23:48) Selection and Sequencing of Therapy for Relapsed/Refractory mUBC — Daniel P Petrylak, MD (47:01) Tolerability/Toxicity of Novel Treatment Strategies and Practical Considerations in the Management of UBC — Guru Sonpavde, MD (1:08:27) CME information and select publications